Shelf life – Page 17

How to Handle Humidity-Sensitive Products in Zone IVb Stability Studies

Managing Humidity-Sensitive Products During Zone IVb Stability Studies In pharmaceutical manufacturing and quality control, the challenges of handling humidity-sensitive products require meticulous planning and execution. Zone IVb, characterized by the…

How to Manage Stability Study Deviations and CAPA

Effective Management of Deviations in Stability Studies and CAPA Implementation Deviations in stability studies can pose significant risks to pharmaceutical manufacturing, impacting product quality and regulatory compliance. These deviations can…

How to Defend Use Immediately After Opening Claims

Defending Use Claims Immediately After Opening: A Practical Guide In the regulated landscape of pharmaceutical manufacturing, defending label claims—especially those made immediately after product opening—can be a critical challenge for…

Climatic Zone Considerations for Oral Liquids and Suspensions

Understanding Climatic Zone Considerations for Oral Liquids and Suspensions Pharmaceutical professionals often face the challenge of ensuring the stability of products in varying environmental conditions. Improper climatic conditions can significantly…

How to Justify Shelf Life Using Stability Study Data

Guide to Justifying Shelf Life with Stability Study Data Pharmaceutical professionals frequently encounter challenges in justifying shelf life for products in various stages of development and production. This article aims…

Label Claim Justification for Lyophilized Product Reconstitution Time

Establishing Label Claim Justification for Reconstitution Time of Lyophilized Products In the pharmaceutical industry, establishing a robust label claim for the reconstitution time of lyophilized products is critical to ensuring…

How Climatic Zone Requirements Affect CTD Stability Sections

Understanding the Impact of Climatic Zone Factors on CTD Stability Sections Pharmaceutical manufacturers face multiple challenges when ensuring the stability of products across different climatic zones. This article aims to…

Stability Studies for Packaging and Container Closure Selection

Addressing Challenges in Stability Studies for Optimal Packaging and Container Closure Selection In the pharmaceutical industry, ensuring the stability of drug products throughout their shelf-life is critical. One of the…

How to Justify Shake Well Claims for Suspensions

Practical Steps for Justifying Shake Well Claims in Suspensions In the realm of pharmaceuticals, justifying label claims regarding suspension products, specifically the directive to “shake well before use,” is crucial…

Stability Planning for Products Moving from EU to ASEAN Markets

Effective Stability Planning for Transitioning Products from EU to ASEAN Markets As pharmaceutical companies expand their markets into ASEAN regions, particularly products transitioning from the EU, understanding the intricacies of…

How to Investigate OOS Results in Stability Studies

Steps to Effectively Investigate OOS Results in Stability Studies Unexpected Out of Specification (OOS) results can pose significant challenges in pharmaceutical stability studies, leading to potential regulatory repercussions and interruptions…

Label Claim Justification for Ophthalmic Preservative-Free Products

Ensuring Justification for Label Claims in Ophthalmic Preservative-Free Products Justifying label claims for ophthalmic preservative-free products poses significant challenges in pharmaceutical manufacturing and quality control processes. As regulatory bodies heighten…